Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
ImExHS. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
ImExHS's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ImExHS has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare ImExHS's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare ImExHS's earnings growth to the Germany market average as no estimate data is available.
Unable to compare ImExHS's revenue growth to the Germany market average as no estimate data is available.
Unable to determine if ImExHS is high growth as no earnings estimate data is available.
Unable to determine if ImExHS is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
ImExHS's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. German Arango is Chief Executive Officer and Managing Director at ImExHS Limited since August 28, 2018. Dr. Arango has been a Director of ImExHS Limited (formerly known as Omni Market Tide Ltd.) since August 28, 2018. Dr Arango is the CEO and founder of Imaging Experts and Healthcare Services S.A.S. and has over 14 years’ experience as a practising radiologist in Colombia, with a degree in Diagnostic Neuroradiology from McGill University, Montreal, Canada. Dr Arango is currently the Chairman and Staff Neuroradiologist at Mederi-Hospital Universitario Mayor, Bogota Colombia and has practised as a Neuroradiologist in various hospitals and clinics in Colombia. Dr Arango is the Associate Professor of Diagnostic Neuroradiology for the neurology and neurosurgery residency programmes for University El Rosario at Mederi – Hospital Universitario Mayor and has held various Associate Professor of Diagnostic Neuroradiology roles for Universidad Miltar de Colombia, Fundacion Universitaria de Ciencias de la Salud, Universidad Nacional de Colombia and El Bosque University during the period from 2006 to 2012.
Insufficient data for German to compare compensation growth.
Insufficient data for German to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
MD, CEO & Director
Chief Financial Officer
Chief Sales Officer
Chief Medical Officer
Board of Directors Tenure
Average tenure of the
board of directors in years:
The average tenure for the ImExHS board of directors is less than 3 years, this suggests a new board.
Board of Directors
MD, CEO & Director
Former Chairman of the Board
Who owns this company?
Recent Insider Trading
More shares have been bought than sold by ImExHS individual insiders in the past 3 months.
Who Are The Largest Shareholders In Omni Market Tide Limited (FRA:A4B)?
View our latest analysis for Omni Market Tide DB:A4B Ownership_summary Apr 12th 18 Insider Ownership Insiders form another group of important ownership types as they manage the company's operations and decide the best use of capital. … With this size of ownership, retail investors can collectively play a role in major company policies that affect shareholders returns, including executive remuneration and the appointment of directors. … Private Company Ownership Potential investors in A4B should also look at another important group of investors: private companies, with a stake of 2.05%, who are primarily invested because of strategic and capital gain interests.
Does Omni Market Tide Limited's (FRA:A4B) PE Ratio Warrant A Buy?
It compares a stock’s price per share to the stock’s earnings per share. … Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for A4B Price per share = A$0.01 Earnings per share = A$0.001 ∴ Price-Earnings Ratio = A$0.01 ÷ A$0.001 = 20.2x On its own, the P/E ratio doesn’t tell you much; however, it becomes extremely useful when you compare it with other similar companies. … A4B’s P/E of 20.2x is lower than its industry peers (36.4x), which implies that each dollar of A4B’s earnings is being undervalued by investors.
Omni Market Tide Limited (FRA:A4B): Can It Deliver A Superior ROE To The Industry?
Omni Market Tide Limited (DB:A4B) generated a below-average return on equity of 4.69% in the past 12 months, while its industry returned 12.44%. … View our latest analysis for Omni Market Tide What you must know about ROE Return on Equity (ROE) weighs Omni Market Tide’s profit against the level of its shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is measured against cost of equity in order to determine the efficiency of Omni Market Tide’s equity capital deployed.
Interested In Omni Market Tide Limited (FRA:A4B)? Here's How It Performed Recently
Measuring Omni Market Tide Limited's (DB:A4B) track record of past performance is an insightful exercise for investors. … DB:A4B Income Statement Mar 12th 18 We can further examine Omni Market Tide's loss by looking at what the industry has been experiencing over the past few years. … Each year, for the past five years Omni Market Tide's top-line has increased by 27.83% on average, indicating that the company is in a high-growth period with expenses shooting ahead of revenues, leading to annual losses.
ImExHS Limited operates as an imaging software as a service and ancillary service provider in Latin America. It is involved in developing and selling Hiruko software platform that comprises radiology information system, which manages the workflow management system with a patient data and image distribution system, as well as picture archiving and communication system that allows healthcare organization to capture, store, view, and share radiology images. The company was founded in 2012 and is headquartered in Mascot, Australia.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.